Report Date | |
Manager | |
Fund Name | |
Strategy | |
Latest Return Date | |
Latest Return | |
Latest 6 Months | |
Latest 12 Months | |
Latest 24 Months (pa) | |
Annualised Since Inception | |
Inception Date | |
FUM (millions) | |
Fund Overview | The Fund's discretionary investment strategy commences with a macro view of the economy and direction to establish the portfolio's desired market exposure. Following this detailed sector and company research is gathered from knowledge of the individual stocks in the Fund's universe, with widespread use of broker research. Company visits, presentations and discussions with management at CEO and CFO level are used wherever possible to assess management quality across a range of criteria. Detailed analysis of company valuations using financial statements and forecasts, particularly focusing on free cash flow, is conducted. Technical analysis is used to validate the Manager's fundamental research and valuations and to manage market timing. A significant portion of the Fund's overall performance can be attributed to the attention and importance given to the macro economic outlook and the ability and willingness to adjust the Fund's market risk. |
Manager Comments | The best performers in the portfolio in August included stocks leveraged to new technologies whilst more defensive stocks lagged. Positive contributors included Zip Co, Pointsbet, Harvest Technology, Kogan and Charter Hall. Key detractors included West African, Aroa Biosurgery, National Australia Bank, Pilbara and Polynovo. Kardinia increased net market exposure modestly to 74.5% (90.0% long and 15.5% short), with the key changes being new positions in NRW Holdings, Qantas, Redbubble and Vicinity Centres, as well as increased weightings in Austal, Alumina, Flight Centre and Pointsbet. This was partially offset by a short position in Share Price Index Futures. Kardinia believe the portfolio has a good mix of stocks that benefit from both a lockdown scenario and a re-opening scenario, with more recent additions resulting in a tilt towards the latter. They believe good progress is being made on potential vaccines and treatments and expect Governments will increasingly move towards a 'living with the virus' approach as the economic damage from lockdowns becomes apparent. |
More Information |